Clareo Health | A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
Moderate or severe glabellar lines (GL) at maximum frown as assessed by both the investigator and participant using the Facial Wrinkle Scale (FWS) at Screening and Baseline (Day 1) Visits
Must be in good health as per investigator's judgment based on medical history, physical examination, vital sign measurements, and 12-lead ECG parameters
Must have sufficient visual acuity without the use of eyeglasses (contact lens use is acceptable) to accurately assess their GL, in the opinion of the investigator.
You may not be if
Severe glabellar lines at rest as assessed by the investigator using the FWS
Prior exposure to botulinum neurotoxin of any serotype within the last 12 months prior to screening
History of hypersensitivity to any botulinum neurotoxin serotype or any other constituents of the study drug
